Targeting Cancer Therapy with Antibodies
Author Information
Author(s): G.M. Boxer, A.M. Abassi, R.B. Pedley, R.H.J. Begent
Primary Institution: Cancer Research Campaign Laboratories, University Department of Clinical Oncology, Royal Free Hospital School of Medicine
Hypothesis
The distribution of antigen epitopes influences the targeting efficiency of monoclonal antibodies in colorectal adenocarcinoma.
Conclusion
The A5B7 antibody shows superior localization to the basement membrane of malignant glands compared to the EA77 antibody, which is primarily found on lumenal surfaces.
Supporting Evidence
- A5B7 antibody localized more effectively to the basement membrane of malignant glands than EA77.
- EA77 showed a significant difference in reactivity between the lumenal surface and the basement membrane aspect.
- Immunohistochemical reactivity of antibodies was assessed using a scoring system.
- Statistical analysis showed significant differences in antibody localization.
- Antibody localization was studied in a human tumor xenograft model.
Takeaway
This study looked at how well different antibodies can find and stick to cancer cells. One antibody was much better at getting to the right spot than the other.
Methodology
The study used immunohistochemistry and in vivo localization in a human tumor xenograft model to compare the targeting efficiency of two monoclonal antibodies.
Limitations
The study is limited to a specific type of cancer and may not generalize to other cancers or antibody types.
Participant Demographics
The study involved samples from patients with colorectal adenocarcinoma.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website